DRY TRANSFECTION COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME

(19)

(11)

EP 3 065 711 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	16.10.2024 Bulletin 2024/42

(45)	Mention of the grant of the patent:
	04.09.2024 Bulletin 2024/36

(21)	Application number: 14860556.1

(22)	Date of filing: 23.10.2014

(51)

International Patent Classification (IPC):

A61K 9/14^(2006.01)
A61K 48/00^(2006.01)
A61K 9/00^(2006.01)

A61K 47/00^(2006.01)
A61K 9/51^(2006.01)
C12N 15/87^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61K 9/0019; A61K 47/42; A61K 9/19; A61K 9/204; C12N 15/87; C12N 2740/16052

(86)	International application number:
	PCT/US2014/062011

(87)	International publication number:
	WO 2015/069469 (14.05.2015 Gazette 2015/19)

(54)	DRY TRANSFECTION COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME TROCKENE TRANSFEKTIONSZUSAMMENSETZUNGEN UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON COMPOSITIONS DE TRANSFECTION SÈCHES ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE CELLES-CI

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

05.11.2013 US 201361900232 P

(43)	Date of publication of application:
	14.09.2016 Bulletin 2016/37

(73)	Proprietor: Takara Bio USA, Inc.
	San Jose, CA 95131 (US)

(72)	Inventors:
	QUINN, Thomas Patrick Sunnyvale, California 94086 (US) MITRA, Sayantan Mountain View, California 94043 (US)

(74)	Representative: Carpmaels & Ransford LLP
	One Southampton Row London WC1B 5HA London WC1B 5HA (GB)

(56)

References cited: :

WO-A2-2005/055979
US-A1- 2002 131 951
US-A1- 2011 008 894
US-B2- 7 427 394

WO-A2-2005/055979
US-A1- 2006 083 711
US-B2- 6 998 115

SUNSHINE J C ET AL: "Poly(beta-Amino Ester)-Nanoparticle Mediated Transfection of Retinal Pigment Epithelial Cells In Vitro and In Vivo", PLOS ONE, vol. 7, no. 5, 21 May 2012 (2012-05-21), pages E37543-1 - 11, XP002746169, ISSN: 1932-6203, [retrieved on 20120521], DOI: 10.1371/JOURNAL.PONE.0037543

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).